📢 Publish Your Research for Free - Full APC Waiver, No Hidden Charges. Submit Your Article Today! Submit Now →

Editor Profile

editor profile image is not found.

Dr. Riyaz Bhat, M.D.

Consultant Physician

Present

King Saud Medical City

Riyadh

Saudi Arabia

editor profile QR Code is not found.

Dr. Riyaz Bhat, MD (Internal Medicine)

Dr. Riyaz is a highly experienced Consultant Physician with 16 years of clinical expertise in Internal Medicine and its allied specialties. With a career spanning over a decade and a half, including a significant tenure at King Saud Medical City, he has developed a profound mastery of complex multi-system diagnostics and the management of acute and chronic pathologies.

A dedicated academician, Dr. Riyaz has contributed extensively to medical literature with a portfolio of 24 publications in national and international professional journals. His research and clinical practice are defined by a multidisciplinary approach, bridging the gap between clinical observation and evidence-based publication. His expertise extends beyond the bedside into medical authorship and technical production, making him a seasoned voice in the dissemination of high-impact medical research.

  • Internal Medicine & Multi-System Disorders: Comprehensive management of complex clinical presentations.
  • Gastroenterology & Hepatology: Clinical research and Interest in Liver Diseases and its manifestations. Advanced Medical therapies involved and their evolution.
  • Cardiology & Diagnostic Testing: Management of cardiovascular syndromes within internal medicine.
  • Quality Improvement & Clinical Protocols: Enhancing healthcare delivery systems and patient safety through rigorous clinical standards.
  • Endocrinology & Rheumatology: Specialized focus on connective tissue diseases, metabolic bone health, and hormonal regulation.
  • Bhat RA*, Laway BA, Zargar AH. Prevalence of metabolic syndrome in the Kashmir valley of the Indian subcontinent. Indian J Med Sci 2010; 64:259-64.
  • Bhat RA*, Khan I, Khan I, Palla N, Mir T. Emphysematous pyelonephritis: Outcome with conservative management. Indian J Nephrol 2013; 23:444-7.
  • Parry IA, Bhat RA*, Khan I. The prevalence of non-alcoholic fatty liver disease and its association with metabolic syndrome and obesity in the pediatric population of North India. J Metabolic Synd 2012; 1:118. Doi:10.4172/2167-0943.1000118
  • Bhat RA*, Parray I, Ahmad Z. Prevalence of the metabolic syndrome among North Indian adolescents using Adult Treatment Panel III and Pediatric International Diabetic Federation definitions. J Diabetes Metab 2014; 5:352. Doi:10.4172/2155-6156.1000352
  • Bhat RA*, Khan I, Mir T, Khan I, Wani M. Systemic lupus erythematosus presenting as acute adrenal insufficiency: A rare clinical presentation. Ann Med Health Sci Res 2014; 4:140-2.
  • Bhat RA. Factor analysis of metabolic syndrome components in the North Indian adult population of Kashmir. J Med Soc 2015; 29:83-7.
  • Khan I, Bhat RA, Khan I, Saleem T. Association of posterior reversible encephalopathy syndrome with renal failure. British Journal of Medicine 3 Medical Research 2015; 11:1096-1100.
  • Bhat RA, Wani Z, Baasit S, Khan I. Clinical course, laboratory parameters, and outcome of TTP pediatric patients presenting with posterior reversible encephalopathy syndrome. Ren Fail 2015; 37:974-9.
  • Wani ZA, Bhat RA, Bhadoria AS, Maiwall R. Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: Need for a new classification. Saudi J Gastroenterol 2015; 21:129-38.
  • Wani ZA, Baht RA, Bhadoria AS, Maiwall R, Majeed Y, Khan AA, Zargar SA, Shah MA, Khan KM. After proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis? Saudi J Gastroenterol 2015; 21:278-83.
  • Wani ZA, Bhat RA, Bhadoria AS, Zargar SA, Shah AH, Maiwall R, Hameed I, Basit S. A haemodynamic analysis to assess the safe dose of carvedilol across different child classes of liver disease. British Journal of Medicine 3 Medical Research 2015; 7:355-368.
  • Wani ZA, Bhat RA, Bhadoria AS, Maiwall R, et al. Does acute response to a safe dose of carvedilol vary across different child classes of liver disease: A large cohort haemodynamic study. Int J Health Allied Sci 2016; 5:1-8.
  • Wani ZA, Baht RA, Bhadoria AS, Maiwall R, Choudhury A. Gastric varices: Classification, endoscopic and ultrasonographic management. J Res Med Sci 2015; 20:1200-7.
  • Khan I, Bhat RA, Khan I, Hameed I. Grave's disease associated with immunoglobulin A nephropathy: A rare association. Indian J Nephrol 2015; 25:248-50.
  • Bhat RA*, Wani I, Khan I, Wani M. Renal allograft transplant recipient with ruptured hydatid native kidney. Urol Ann 2014; 6:267-9.
  • Wani ZA, Bhat RA*, Khan I, Khan I, Saleem T, Wani Z. Prevalence and predictors of carotid artery atherosclerosis and its association with coronary artery disease in the North Indian population. Nig J Cardiol 2014; 11:84-7.
  • Bhat RA*, Bashir G, Wani M, Lone S. Emphysematous pyelonephritis caused by Candida parapsilosis: An unknown etiological agent. North Am J Med Sci 2012; 4:364-6.
  • Bhat RA*, Khan I, Khan I, Mir MA. Polycythemia, increased erythropoietin levels in a patient with renal lymphoma. Adv Biomed Res 2014; 3:147.
  • Hameed I, Masoodi SR, Dil-Afroze, Bhat RA, et al. CTTTA deletion/insertion polymorphism in the 3'-UTR of the LEPR gene in type 2 diabetes subjects belonging to the Kashmiri population. J Diabetes Metab Disord 2014; 13:124.
  • Ganie MA, Bhat RA, Irfan-ul-Qayoom, Dangroo MA, Kotwal S, Bhat MA, Ahmed S, Hassan S, Shah ZA. Unassisted successful pregnancy in a case of Addison's disease with recurrent pregnancy loss. Indian J Endocr Metab 2012; 16:481-2.
  • Hameed I, Masoodi SR, Dil Afroze, Naykoo NA, Bhat RA, Ganai BA. Trp homozygotes at codon 64 of the ADRB3 gene are protected against the risk of type 2 diabetes in the Kashmiri population. Genet Test Mol Biomarkers 2013; 17:775-779.
  • Iqra Hameed, Shariq R. Masoodi, Dil Afroze, Niyaz A. Naykoo, Riyaz A. Bhat, and Bashir A. Ganai. Trp Homozygotes at Codon 64 of ADRB3 Gene Are Protected Against the Risk of Type 2 Diabetes in the Kashmiri Population. Genetic Testing and Molecular Biomarkers 2013; 17:775-779.
  • Iqra Hameed, Dil Afroze, Shariq R. Masoodi, Riyaz A. Bhat, and Bashir A. Ganai. Screening Codon 233, 234, and 276 Polymorphisms in Exon of Insulin Receptor Gene in Type 2 Diabetes Mellitus Patients of Kashmir Valley. IOSR Journal of Pharmacy and Biological Sciences 2012; 3:07-10.
  • Wani MM, Khan I, Bhat RA, and Ahmad M. Fabry's Disease: Case Series and Review of Literature. Ann Med Health Sci Res 2016; 6(3):193-197.
    No content available to display!!!